Prognostic impact of onset timing on response to methylprednisolone pulse therapy for idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation.

Sano H, Yanagi M, Hori D, Matsushima S, Ishigaki R, Ohshima J, Suzuki D, Kobayashi R

Open source

DOI
10.1080/08880018.2026.2636608
Published
2026 Apr-May
Container
Pediatric hematology and oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/08880018.2026.2636608,
  title = {Prognostic impact of onset timing on response to methylprednisolone pulse therapy for idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation.},
  author = {Sano H and Yanagi M and Hori D and Matsushima S and Ishigaki R and Ohshima J and Suzuki D and Kobayashi R},
  year = {2026},
  journal = {Pediatric hematology and oncology},
  doi = {10.1080/08880018.2026.2636608},
  url = {https://doi.org/10.1080/08880018.2026.2636608}
}

RIS

TY  - JOUR
TI  - Prognostic impact of onset timing on response to methylprednisolone pulse therapy for idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation.
AU  - Sano H
AU  - Yanagi M
AU  - Hori D
AU  - Matsushima S
AU  - Ishigaki R
AU  - Ohshima J
AU  - Suzuki D
AU  - Kobayashi R
PY  - 2026
JO  - Pediatric hematology and oncology
DO  - 10.1080/08880018.2026.2636608
UR  - https://doi.org/10.1080/08880018.2026.2636608
ER  - 

APA

H, S., M, Y., D, H., S, M., R, I., J, O., D, S., & R, K. (2026). Prognostic impact of onset timing on response to methylprednisolone pulse therapy for idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation.. Pediatric hematology and oncology. https://doi.org/10.1080/08880018.2026.2636608

Source records